Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics

Didier, Capucine; Streicher, Marie-Pierre; Chognot, Didier; Campagni, Raphaèle; Schnebelen, Albert; Messer, Jean; Donato, Lionel; Langer, Bruno; Meyer, Nicolas; Astruc, Dominique; Kuhn, Pierre
April 2012
European Journal of Pediatrics;Apr2012, Vol. 171 Issue 4, p681
Academic Journal
Widespread use of intrapartum antimicrobial prophylaxis has significantly reduced the incidence of early-onset neonatal infection (EONI); however, little is known about the effects of increased maternal exposure to antibiotics on late-onset neonatal infection (LONI). This study aims to evaluate LONI epidemiology in our region after the application of French recommendations and to determine whether LONI-causing organisms and their antibiotic susceptibility are influenced by peripartum antibiotic exposure. We performed a prospective epidemiologic study of 139 confirmed and possible cases of bacterial LONI in patients treated with antibiotics for at least 5 days of the 22,458 infants born in our region in the year 2007. The overall incidence of LONI caused by all pathogens, Group B streptococcus ( GBS) and Escherichia coli ( E. coli) were 6.19, 0.36 and 2.72, respectively, per 1,000 live births. Our findings revealed three major types of LONI: E. coli-induced urinary tract infection (UTI) among term infants, coagulase negative Staphylococcus septicemia affecting preterm infants, and GBS infections with severe clinical presentation. Univariable analysis revealed that maternal antibiotic exposure was significantly associated with the risk of amoxicillin-resistant E. coli infection ( p = 0.01). Postnatal antibiotic exposure was associated with an increased risk of E. coli LONI ( p = 0.048). This link persisted upon multivariable analysis; however, no additional risk factors were identified for LONI caused by antibiotic-resistant E. coli. Conclusion Our findings confirm that despite the benefits of antenatal antibiotics, this treatment can increase the risk of antibiotic-resistant cases of LONI. National and international surveillance of LONI epidemiology is essential to assess benefits and potential negative consequences of perinatal antibiotic exposure.


Related Articles

  • Post-operative spondylodiscitis. Nasto, L. A.; Colangelo, D.; Rossi, B.; Fantoni, M.; Pola, E. // European Review for Medical & Pharmacological Sciences;2012 Supplement, Vol. 16, p50 

    Postoperative spine infections (PSIs) are a frequent and dreaded complication of spine surgery. Although different studies have been published, the prevalence of PSIs is thought to be about 5% for most spine surgical procedures. Different risk factors have been identified for PSIs. Among the...

  • Application of the antibiotic batumin for accurate and rapid identification of staphylococcal small colony variants. Churkina, Larisa N; Bidnenko, Svetlana I; dos Santos Santiago, Guido Lopes; Vaneechoutte, Mario; Avdeeva, Lilja V; Lutko, Olga B; Oserjanskaja, Nadya M // BMC Research Notes;2012, Vol. 5 Issue 1, p374 

    Background: Staphylococcus aureus is a major human pathogen causing significant morbidity and mortality. The S. aureus colonies in osteomyelitis, in patients with cystic fibrosis and patients with endoprosthesis rejection frequently have an atypical morphology, i.e. staphylococcal small-colony...

  • Staphylococcal sepsis in UK neonatal units.  // Archives of Disease in Childhood;Mar2012, Vol. 97 Issue 3, p210 

    The article discusses the occurrence of neonatal infection, particularly staphylococcus aureus infection, between 2004 and 2009 in neonatal units in Great Britain.

  • Bugging the Bugs: Novel Approaches in the Strategic Management of Resistant Staphylococcus aureus Infections. Kollef, Marin H. // Clinical Infectious Diseases;9/15/2007 Supplement, Vol. 45, pS163 

    The article focuses on new approaches to be adopted to strategically manage resistant staphylococcus aureus infections. In the U.S., 60% of staphylococcal infections in inpatients are now caused by methicillin-resistant Staphylococcus aureus (MRSA). A de-escalation approach starting with...

  • Staphylococcus aureus Host Cell Invasion and Virulence in Sepsis Is Facilitated by the Multiple Repeats within FnBPA. Edwards, Andrew M.; Potts, Jennifer R.; Josefsson, Elisabet; Massey, Ruth C. // PLoS Pathogens;Jun2010, Vol. 6 Issue 6, p1 

    Entry of Staphylococcus aureus into the bloodstream can lead to metastatic abscess formation and infective endocarditis. Crucial to the development of both these conditions is the interaction of S. aureus with endothelial cells. In vivo and in vitro studies have shown that the staphylococcal...

  • Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans. Sun Hee Ahn; Tsalik, Ephraim L.; Cyr, Derek D.; Yurong Zhang; van Velkinburgh, Jennifer C.; Langley, Raymond J.; Glickman, Seth W.; Cairns, Charles B.; Zaas, Aimee K.; Rivers, Emanuel P.; Otero, Ronny M.; Veldman, Tim; Kingsmore, Stephen F.; Lucas, Joseph; Woods, Christopher W.; Ginsburg, Geoffrey S.; Fowler Jr., Vance G. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Staphylococcus aureus causes a spectrum of human infection. Diagnostic delays and uncertainty lead to treatment delays and inappropriate antibiotic use. A growing literature suggests the host's inflammatory response to the pathogen represents a potential tool to improve upon current diagnostics....

  • Impact of the agr Quorum-Sensing System on Adherence to Polystyrene in Staphylococcus aureus. Cuong Vuong; Saenz, Henri L.; Gotz, Friedrich; Otto, Michael // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    Biofilm formation by Staphylococcus aureus is a serious problem in nosocomial infections. There are great differences in the capacity of S. aureus to express biofilms, but the reasons are unknown. In all, 105 S. aureus strains were tested for a correlation between the agr quorum-sensing system...

  • Norway Stops Superbug.  // Current Science;4/16/2010, Vol. 95 Issue 15, p14 

    The article reports on the move of the Norwegian government to cut back on too much use of antibiotics for the treatment of Staphylococcus aureus infections (MRSA) among patients which have yielded into positive results and reduced the number of people infected by the bacteria.

  • Stem cells serve as new platform for biodefense preparedness. May, Mike // Nature Medicine;Aug2010, Vol. 16 Issue 8, p835 

    The article features the interdisciplinary Life Sciences Building (ILSB) in College Station, Texas, in which researchers can study diseases and toxins. According to a researcher James Sacchettini, the 100 million dollars building will be used for tissue culture. Furthermore, the laboratory is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics